Skip to main content
Premium Trial:

Request an Annual Quote

Elena Hitraya

Crescendo Bioscience has appointed Elena Hitraya as chief medical officer, effective October 1. In this role, she will lead efforts to provide professional education initiatives, to expand market access for Vectra DA, and to develop the company's pipeline of autoimmune products. During the past 11 years, Hitraya has held leadership positions at Genentech, most recently as group medical director for rheumatology/immunology for the Genentech/Roche group. Prior to Genentech, she was regional director of medical affairs for immunology at Cenotocor, a divison of Johnson & Johnson. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more